Blog: The IsoPlexis Data Network

Industry pioneers' backed data straight to your inbox.

Active PD1/PDL1 Trials in 2018
September 11, 2019
Checkpoint Immunotherapy in Solid Tumor Is Evolving: Advancing Cellular Fitness & Precision Medicine with IsoPlexis’ Platform
Read More
checkpoint therapy
September 6, 2019
Single-Cell Functional Proteomics is Leading the Wave in CAR-T Therapies
Read More
Fred Hutch
July 24, 2018
IsoPlexis Launches IsoLight Single-Cell Early Adopter Program
View Article
NEKTAR
June 26, 2018
IsoPlexis Announces Research Collaboration with Nektar Therapeutics
View Article
Single Cell Polyfunctionality of cd4 t cells shows promise as a predictor of overall survival of pancreatic cancer patients treated with GVAX vaccine
June 22, 2018
FOCiS 2018 Day 2: Cancer Vaccine Correlates Revealed through Single-Cell Function
View Article
single-cell highly multiplexed proteomics identifies novel polyfunctional human cd8 t cell signatures induced by a nanoparticle-based melanoma vaccine in human immune system mice
June 20, 2018
FOCiS 2018 Day 1: Cancer Vaccine Correlates Revealed through Single-Cell Function
View Article
Publications
June 12, 2018
Joint Publication with Kite Pharma and NCI in Blood Journal: Preinfusion Polyfunctional Anti-CD19 Chimeric Antigen Receptor T Cells Associate with Clinical Outcomes in NHL
View Article
Pharma top 10
May 15, 2018
IsoPlexis Recognized with the Pharma Tech Outlook Cover Story as Top 10 Analytics Solution Provider in 2018
View Article
Enhanced expansion and tumor targeting of adoptively transferred t cells with nktr-214
April 17, 2018
AACR 2018 Day 3: Increased polyfunctionality observed in samples treated with ACT+NKTR-214 vs ACT+IL-2
View Article
reddot design award winner 2018
,
April 9, 2018
IsoPlexis’ New IsoLight Instrument Receives the Red Dot Design Award for Highest Design Quality
View Article
single-cell cytokine profiling of tumor infiltrating t cells to measure patient responses to anti-pd-1 therapy
February 13, 2018
TRCCC 2018: Single-Cell TILs Polyfunctionality Associates with Clinical Outcome of Anti-PD-1 Therapy
View Article
intratumoral (it) injection of the toll-like receptor 4 (TLR-4) agonist g100 induces a clinical response and a t cell response locally and systemically
January 25, 2018
ASCO-SITC 2018 Day 1: Increase in Polyfunctionality Observed Post Intratumoral Injection of TLR4 Agonist G100
View Article
fierce innovation awards
December 11, 2017
IsoPlexis Wins 2017 Fierce Technology Innovation Award
View Article
single-cell multiplex proteomics reveals synergistic impact of antigen and rimiducid-dependent stimulatory signals on promoting polyfunctional GoCAR-T cells targeting prostate stem cell antigen (PSCA)
December 9, 2017
ASH 2017 Day 1: Synergistic impact of antigen and rimiducid-dependent stimulatory signals on promoting polyfunctional GoCAR-T cells targeting prostate stem cell antigen (PSCA)
View Article
the scientist top 10 innovation award
December 1, 2017
The Scientist Names IsoPlexis Technology The Top Innovation of 2017
View Article
Novartis
November 21, 2017
Journal for ImmunoTherapy of Cancer Highlights New Single Cell Bioinformatics Tools From IsoPlexis Used To Characterize Differences in CAR-T Products
View Article

Categories

Resources

Further Learning